https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/u/34624473

NEW LYME VACCINE: How much vaccine BS (safe and effective) can we tolerate??

Carl Tuttle Hudson, NH, United States

May 17, 2026

—– Forwarded Message —–
From: CARL TUTTLE <runagain@comcast.net>
To: thart15@jh.edu <thart15@jh.edu>
Cc: kremington@ktvn.com <kremington@ktvn.com>; producers@ktvn.com <producers@ktvn.com>
Sent: Sunday, May 17, 2026 at 09:16:59 AM EDT
Subject: Health Watch: Lyme disease vaccine

KTVN 2 News Nevada

Kristen Remington Anchor/Reporter

Health Watch: Lyme disease vaccine

Quote:

“There used to be a Lyme disease vaccine called LYMErix in the late 90’s and early 2000’s. This was eventually pulled off the market due to low sales.” -Thomas M. Hart, PhD

Thomas M. Hart, PhD

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street, E5638

Baltimore Maryland 21205

Dr. Hart,

“Low sales” of the LYMErix vaccine is not the entire truth and has been regurgitated across mainstream media. 

The vaccine known as LYMErix was supposed to expose the immune system to the outer surface protein A (OspA) of the spirochete responsible for causing Lyme disease but for some patients, it caused the same crippling effects of the disease itself as reported in the class action lawsuit:

https://www.dropbox.com/s/sodqs3pdeeesktf/Sheller%20Lymerix.pdf?dl=0

Excerpt from the lawsuit:

“The people who have contacted us were, prior to vaccination with LYMErix, healthy, active and energetic. Indeed, the very reason they sought the LYMErix vaccine was their desire to preserve their healthy, active lifestyle. However, what they experienced was a dramatic degradation of their health and quality of life. As will be described below, these previously healthy individuals are now afflicted with painful, at times debilitating arthritic symptoms, including joint pain and swelling, as well as extremely severe Lyme-disease-like symptoms which have persisted to this day.”

Below is the link to the Final Judgement and Approval of the class action against SmithKline Beecham as a settlement was awarded to these individuals.

JUDGEMENT, FINAL ORDER AND DECREE GRANTING FINAL APPROVAL OF THE CLASS ACTION SETTLEMENT:

https://www.dropbox.com/scl/fi/811ar7u22g1x7vrgiwjhx/2003_Vaccine_Judgement_Final_Sttle_Apprvl..pdf?rlkey=ot1sl13exzgm2bv7ldfe7ks53&dl=0

A chronic relapsing seronegative disease does not fit the vaccine model so chronic Lyme which is completely devastating to the patient is not recognized and there is no treatment. The disabled Lyme patient is left to fend for himself because treating this class of patient became too expensive as outlined in the racketeering lawsuit. There is a growing community of horribly disabled patients whose disability has gone unrecognized for three decades.

Here’s yet another victim:

Nicole Malachowski: Unfit for Duty from Debilitating Tick-Borne Disease

http://cdmrp.army.mil/cwg/stories/2018/nicole_malachowski_profile

“Her medical retirement, however, was premature. At only 43 years old, she was deemed unfit for duty due to neurological damage from tick-borne illness.”

The latest vaccine from French drug manufacturer Valneva is another OspA vaccine similar to LYMErix so the possibility exists that the class of patient who experienced the debilitating effects of LYMErix could end up with the same results. There was no attempt to uncover why LYMErix disabled the patient as described in the class action. Until we fully understand how Lyme disease disables its victim aren’t we playing Russian roulette with people’s health?

Respectfully Submitted,

Carl Tuttle

Independent Researcher

Hudson, NH

Suppressing evidence of persistent infection after antibiotic treatment for Lyme disease is not collaboration, it is collusion:

Peer Reviewed Evidence of Persistence of Lyme Disease Spirochete Borrelia burgdorferi and Tick-Borne Diseases (700 references)

https://www.dropbox.com/s/n09sk90eo6xz7ua/700%20articles%20LYME%20EvidenceofPersistence-V2.pdf?dl=0

For more:

https://childrenshealthdefense.org/defender/breaking-federal-court-strikes-down-landmark-fluoride-ruling-on-technicality-not-science/

Breaking: Federal Court Strikes Down Landmark Fluoride Ruling on Technicality — ‘Not the Science’

Citing a procedural question, a federal appeals court has vacated a landmark decision that found fluoridated drinking water poses an “unreasonable risk” to children’s health. The court sent the case back to the district judge and ordered him to ignore any scientific evidence uncovered after 2020. Attorney Michael Connett told The Defender the court instructed the judge “to travel back in time to 2020 and make this ruling based on a stale factual record.”

by Brenda Baletti, Ph.D.

May 22, 2026

gavel and young boy drinking water

A federal appeals court has vacated a landmark decision that found fluoridated drinking water poses an “unreasonable risk” to children’s health under the Toxic Substances Control Act (TSCA).

The decision by the 9th U.S. Circuit Court of Appeals did not challenge the substance of the lower court’s findings — that fluoride is toxic to children and ought to be regulated. Instead, the court based its decision on procedural issues related to the lower court’s handling of the litigation.

The case will now go back to the U.S. District Court for the Northern District of California, where District Judge Edward Chen will be required to exclude all scientific evidence that became available after 2020.

Michael Connett, attorney for the plaintiffs, told The Defender the court “instructed Judge Chen to travel back in time to 2020 and make this ruling based on a stale factual record.”

Connett said the directive to ignore years’ worth of evidence on fluoride’s dangers runs counter to the intent of the TSCA — which is to protect hundreds of millions of Americans from substances that are harmful to human health.

The federal appeals court ruling, handed down late Thursday, stemmed from a lawsuit against the U.S. Environmental Protection Agency (EPA) brought by consumer advocacy groups including Food & Water Watch, the Fluoride Action Network (FAN), and Moms Against Fluoridation.

The groups sued after the EPA refused to consider their 2016 citizens’ petition asking the agency to regulate fluoride.

After two bench trials, Chen ruled that fluoride at the federally recommended concentration of 0.7 milligrams/liter (mg/L) posed an “unreasonable risk” to children’s health and ordered the EPA to regulate it accordingly.

However, the 9th Circuit panel said the lower court violated the “party presentation principle” — a legal doctrine requiring courts to act as neutral arbiters rather than taking control of a case’s factual development.

The ruling is a procedural victory for the EPA. However, since the trial drew national attention to the extensive evidence of fluoride’s neurotoxic effects, communities and states across the country have stopped adding fluoride to their water.

Even the EPA itself — under a different law — has launched a new investigation into the safety of water fluoridation. (See link for article)

For more:

https://imahealth.substack.com/p/alpha-gal-syndrome-when-a-tick-bite? (Go here for article and video)

Alpha-Gal Syndrome: When a Tick Bite Leads to a Red Meat Allergy

Dr. Ryan Cole joins The National News Desk to explain alpha-gal syndrome, the tick-borne condition that can trigger a sudden allergy to red meat.

Independent Medical Alliance

May 21, 2026

IMA Head of Medical and Scientific Affairs Dr. Ryan Cole joined The National News Desk to break down alpha-gal syndrome, a tick-borne condition that can trigger a sudden allergy to red meat. Dr. Cole explains how the lone star tick transfers a sugar molecule called alpha-1,3-galactose into the bloodstream, which can cause the body to develop an immune reaction to beef, pork, lamb, and other mammalian meats.

The conversation covers why symptoms often appear hours after eating, how repeated tick bites can intensify the reaction, and why the condition is becoming more common as the lone star tick expands its range across the United States. Dr. Cole notes that up to two-thirds of patients see improvement over time, and walks through practical prevention steps for anyone spending time outdoors this season.

Check out these related resources from IMA below, followed by the full segment transcript.

My comment after the article on AGS and the fact the tick is not the sole perp:

Researchers admit they don’t understand the mechanism of action and ticks are not the sole perp, but the perfect scapegoat. A 2009 Australian paper concludes out of 25 patients, only one reported a tick bite 6 months after the onset of meat allergy. One in 5 in the U.S. reported no tick bite at all. In Switzerland, only 1 out of four had a history of tick bite and the authors speculated that there may be other ways of sensitization.

While the Australian researchers inferred that the perp is 1 species of tick, they couldn’t prove it as no lab method exists to check! In the U.S. and Europe, researchers confidently blame different ticks as the sole perps despite meat allergies occurring ‘well outside’ the areas populated by these ticks. Researchers have never been able to confirm that something in tick saliva is responsible for AG antibodies.

https://madisonarealymesupportgroup.com/2025/09/03/ags-ticks-a-false-trail/ (Gelatin-containing vaccines and bovine serum albumin (BSA) used in cell cultures that produce vaccines are implicated due to causing hypersensitivity reactions, especially after repeated shots)

Lastly, independent tick research has proven the climate has ZERO to do with tick and disease proliferation:  https://madisonarealymesupportgroup.com/2018/11/07/ticks-on-the-move-due-to-migrating-birds-and-photoperiod-not-climate-change/ There’s huge government money for researchers studying ‘climate change.’

It is far more likely that the spread of ticks and their diseases is due to our very own government doing research stuffing them with multiple pathogens and then releasing them into the environment:  https://madisonarealymesupportgroup.com/2026/03/06/declassified-docs-link-bioweapon-program-to-lyme-disease/

For far too long we’ve been told ticks don’t exist in certain areas, therefore you can’t be infected, so you won’t be treated.  https://madisonarealymesupportgroup.com/2018/05/31/no-lyme-in-the-south-guess-again/

Tell that to the mouse, squirrel, bird, fox, reptile, deer, and virtually every other animal, including humans that they can’t cross state borders!

Parasite, Biowarfare & Cancer

Go here to listen to Dr. Lee Merritt discuss the history of parasites, biowarfare and cancer.

According to Merritt, the story of the CIA covering up the cure for cancer is pure bunk. The CIA didn’t exist when the truth about cancer was covered up. Merritt shows  the proof–what we knew about cancer before 1930, and how Cancer research has been used–not just by us–as a cover for bioweapons research. And she believes it is actively being used as a bioweapon against us today.

The silver lining of COVID tyranny is that it affected nearly everyone in some form or fashion. Suffering has a way of opening eyes to the fact our government is not our friend, does not care about our well-being, and is in bed with Big Pharma – actually peddling their products for financial gain.  Once you know this, things start making a lot more sense.  Further, research institutions are beholden to this very corrupt, conflict riddled government for research grants which means they can’t be trusted either.  The same goes for the academic publishing cartel. And lastly, the media is essentially a prostitute who will do anything for money, including accepting money from drug makers.

So, there you have it.  The current lovely state of things.

With all of this said, it would be prudent to question everything our government, research, and media tells us because if they lie in one area, rest assured – they aren’t above lying in another area.  

Our government health ‘experts’ attack anything that they don’t have their fingers on.  There’s been a long, sordid history of the FDA attacking natural supplements, hormones, and anything Big Pharma considers a threat. Rather than addressing real issues like the excess levels of electromagnetic radiation, or ending the decades long addition of fluoride to water after research proves it lowers intelligence, our tax dollars are at work attacking safe treatments like homeopathy, supplements like NAC, natural thyroid hormones, and ivermectin – a proven, safe drug on the WHO list of essential medicines.

Which brings us to cancer – the massively lucrative elephant in the room.

Recently, a published cancer study linking the COVID shot to cancer simply disappeared.  That’s right.  Poof!  Another cancer journal was hit with cyberattacks after confirming over 300 peer-reviewed COVID shot cancer cases across 27 countries.  The evidence continues to pile up but no admissions are forth-coming, so don’t hold your breath.

But, there is some good news in this muddy pig-pen.  Red-pilled, frustrated doctors are finding many alternative cancer treatments that appear to be working and have a much higher safety profile than current new treatments, which according to a new review only help fewer than 2% of patients.

A few of these successful cancer treatments are anti-parasitic medications.

It’s important to learn about the history and Merritt is highly qualified to give that lesson.  Go to top link to hear it.

 

https://thevaccinereaction.org/2026/04/study-finds-all-major-pharmaceutical-companies-implicated-in-bribery-schemes/

Study Finds All Major Pharmaceutical Companies Implicated in Bribery Schemes

A study published in February 2026 in the Journal of Law, Medicine & Ethics is the first to compile decades of Organization for Economic Cooperation and Development (OECD) enforcement records into a single analysis. Researchers Kohler, Khan, and Bowra reviewed OECD Working Group on Bribery reports from 1999 through early 2025 and found that virtually every major pharmaceutical company operating globally has been implicated in at least one foreign bribery scheme.1

The underlying cases were drawn from U.S. Department of Justice and Securities and Exchange Commission enforcement actions documented over many years. Together, they reveal a pattern of corruption spanning dozens of countries and totaling more than one billion dollars in penalties.

Pfizer, GlaxoSmithKline, Sanofi Among Vaccine Companies Implicated

The researchers identified 21 investigations involving 19 pharmaceutical companies and numerous subsidiaries across five OECD member nations. The United States accounted for 14 of those investigations, followed by Germany and Denmark with three each, and Greece and Italy with one each.2 Among the companies publicly named were Pfizer, Johnson & Johnson, Novartis, Teva, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, Sanofi, Eli Lilly, Novo Nordisk, SciClone, BioTest, and Nordion.3

The study defines bribery as “the offering, promising, giving, accepting or soliciting of an advantage as an inducement for an action which is illegal, unethical or a breach of trust.”4

The authors explain:

… pharmaceutical company bribes and other financial inducements can distort prescribing and compromise regulations that are designed to ensure drug safety and efficacy. More generally, pharmaceutical industry corruption affects patient safety and health care resource allocation worldwide.5

Over One Billion Dollars in Sanctions Paid Out by Companies

The implicated companies paid a combined $1,111,225,911 in sanctions. That total included $586,263,414 in fines, $447,237,274 in returned profits, and $77,545,872 in prejudgment interest.6 Despite the scale of the financial penalties, not one company admitted wrongdoing in any of the 21 cases.7

How the Bribery Schemes Operated

The study found that bribery schemes were not isolated acts by low-level employees acting on their own. Rather, senior executives and regional directors within the drug companies approved and, in some cases, directed the payments. Subsidiaries, shell companies, and third-party vendors were used to route payments and give them the appearance of legitimacy. Twelve of the 19 investigations found that subsidiaries were used specifically to conceal bribery operations. The bribes were used to secure regulatory approvals, influence prescribing patterns, and drive drug sales in markets around the world.8

Bribes Hidden in Distributor Discounts

A second pattern identified in the study involved pharmaceutical companies granting unusually steep discounts to distributors. The distributors then used the excess funds to pay bribes to physicians and government officials. Companies falsely recorded the discounts as legitimate marketing or sales expenses, concealing the payments in their books.

The arrangement had a direct consequence for patients. When physicians received payments tied to a particular drug, their prescribing decisions were driven by financial benefit rather than patient need.10

Novartis Vietnam worked with a distributor that paid bribes directly to healthcare providers and reimbursed up to 50 percent of those costs through credit notes. Teva Mexico funneled cash to physicians through a Copaxone distributor and mislabeled the payments as revenue reductions. Eli Lilly’s Brazilian subsidiary granted discounts of 17 to 19 percent instead of the standard 10 percent, concealing a six percent bribe to state officials within the markup.11

Novartis

Between 2012 and 2015, a Novartis subsidiary in Greece bribed employees at state-owned hospitals and clinics to increase prescriptions for Lucentis, a drug used to treat macular degeneration. Physicians were paid more than $5,000 per event attended. Internal Novartis documents described the arrangement as a return on investment and tied physician payments to their prescription volumes.12

In South Korea, a Novartis subsidiary channeled more than $16.3 million through third-party medical journals as improper payments to physicians. In June 2020, Novartis and its subsidiaries agreed to pay $345 million to resolve Foreign Corrupt Practices Act charges brought by the U.S. Department of Justice (DOJ) and the Securities and Exchange Commission (SEC). Novartis Hellas SACI paid a criminal penalty of $225 million and entered a three-year deferred prosecution agreement.13

Johnson & Johnson

In Greece, Poland, and Romania, Johnson & Johnson subsidiaries and agents used slush funds, sham contracts, and offshore accounts in the Isle of Man to reward physicians and hospital administrators. The drug company was also accused of paying kickbacks in Iraq.

Johnson & Johnson agreed to pay more than $48 million to resolve SEC charges and $21.4 million to resolve parallel DOJ criminal charges. However, the large pharmaceutical company did not admit or deny the allegations.14

Pfizer

Pfizer subsidiaries in Italy and Russia were accused by the SEC in 2012 of paying bribes over approximately a decade to foreign government officials. They paid the bribes in order to secure regulatory and formulary approvals, boost sales, and increase prescriptions.

After voluntarily disclosing the misconduct in 2004, Pfizer agreed to pay $26.3 million to the SEC to resolve the charges. Its subsidiary Pfizer HCP paid a separate $15 million criminal penalty to the DOJ. Like the other big pharmaceutical companies, Pfizer did not admit or deny the allegations.15

Teva

Teva Pharmaceuticals made illicit payments to government officials in Russia, Ukraine, and Mexico to increase market share, according to the U.S. Department of Justice and the SEC. Those payments generated $214 million in illegal profits. Teva agreed to pay $283 million in criminal fines to the DOJ and $236 million in disgorgement and prejudgment interest to the SEC, for a combined total of $519 million.16

GlaxoSmithKline

GlaxoSmithKline’s subsidiary in China was fined CN¥3 billion by Chinese authorities after an investigation found it had bribed physicians to increase drug sales. It was the largest fine imposed by a Chinese court at the time. The Securities and Exchange Commission later resolved Foreign Corrupt Practices Act charges against the company for the same conduct, settling for $20 million.17

AstraZeneca and Sanofi

AstraZeneca paid $5.5 million to the SEC to resolve charges that it made improper payments to government-controlled healthcare providers in China and Russia.18 Sanofi settled Foreign Corrupt Practices Act charges with the SEC for $25.2 million in 2018. The agency found that employees and agents in multiple countries made improper payments to foreign officials, including physicians, between 2011 and 2015.19

Zero Admissions of Wrongdoing

Across all 21 investigations spanning more than two decades of OECD monitoring, no pharmaceutical company admitted any wrongdoing. Companies paid the over one billion dollars in combined penalties and moved forward. The study’s authors concluded that bribery in the pharmaceutical sector is not an isolated event but a systemic and recurring feature of how some of the world’s largest drug companies have operated in markets across the globe.20 21

The authors suggest that the wide-spread pattern of bribery across the pharmaceutical industry is indicative of institutional corruption. Both the legal and illegal acts of bribery by big pharma “pervert institution’s function under conditions that may promote personal benefit” and serve to undermine the public.

Click top link to view References